Aline Gonzalez Vigani

Summary

Affiliation: Universidade Estadual de Campinas
Country: Brazil

Publications

  1. doi request reprint The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C
    A G Vigani
    Departamento de Clinica Medica, Universidade Estadual de Campinas UNICAMP, Campinas, Sao Paulo, Brazil
    J Viral Hepat 18:e91-8. 2011
  2. doi request reprint Hepatitis C infection and chronic renal diseases
    Aline Gonzalez Vigani
    Departamento de Clínica Médica da Disciplina de Moléstias Infecciosas, Grupo de Estudo das Hepatites Virais, Universidade Estadual de Campinas UNICAMP, Campinas, Brazil
    Hepatol Int 7:16-27. 2013
  3. ncbi request reprint Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
    Aline Gonzalez Vigani
    Viral Hepatitis Study Group, Universidade Estadual de Campinas, Campinas, SP, Brazil
    Braz J Infect Dis 16:232-6. 2012
  4. pmc Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Goncales
    Grupo de Estudo das Hepatites, Disciplina de Doenças Infecciosas, Departamento de Clinica Medica, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas, UNICAMP, Sao Paulo, Brazil
    BMC Infect Dis 10:212. 2010
  5. pmc Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
    Priscila A Tonetto
    Grupo de Estudo das Hepatites Disciplina de Moléstias Infecciosas, Departamento de Clínica Médica Faculdade de Ciências Médicas Universidade Estadual de Campinas UNICAMP, Sao Paulo, Brazil
    BMC Infect Dis 9:149. 2009
  6. pmc Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil
    Aline G Vigani
    Grupo de Estudos das Hepatites Virais, Departamento de Clinica Medica, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas UNICAMP, Sau Paulo, Brasil
    BMC Infect Dis 8:164. 2008
  7. ncbi request reprint Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
    Aline Gonzalez Vigani
    Viral Hepatitis Study Group, Department of Medical Clinic, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas, Campinas, Brazil
    Braz J Infect Dis 14:193-6. 2010

Detail Information

Publications7

  1. doi request reprint The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C
    A G Vigani
    Departamento de Clinica Medica, Universidade Estadual de Campinas UNICAMP, Campinas, Sao Paulo, Brazil
    J Viral Hepat 18:e91-8. 2011
    ..We also provide the first evidence for an association between cryoglobulinemia and higher SVR rates, highlighting its potential role as a prognostic factor for treatment response...
  2. doi request reprint Hepatitis C infection and chronic renal diseases
    Aline Gonzalez Vigani
    Departamento de Clínica Médica da Disciplina de Moléstias Infecciosas, Grupo de Estudo das Hepatites Virais, Universidade Estadual de Campinas UNICAMP, Campinas, Brazil
    Hepatol Int 7:16-27. 2013
    ..In this review, we will attempt to provide the most recent insights on HCV infection both as a extrahepatic manifestations and as a complication of end-stage renal patients. ..
  3. ncbi request reprint Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
    Aline Gonzalez Vigani
    Viral Hepatitis Study Group, Universidade Estadual de Campinas, Campinas, SP, Brazil
    Braz J Infect Dis 16:232-6. 2012
    ..Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes 2 or 3, but its efficacy compared to Peg-IFN is unknown...
  4. pmc Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Goncales
    Grupo de Estudo das Hepatites, Disciplina de Doenças Infecciosas, Departamento de Clinica Medica, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas, UNICAMP, Sao Paulo, Brazil
    BMC Infect Dis 10:212. 2010
    ..The aim of this study was to evaluate the efficacy of retreatment with Peg-Interferon alpha-2b (PEG-IFN alpha-2b) plus RBV, in patients with HCV, genotypes 1 or 3, who were non-responders to the previous standard treatment with IFN/RBV...
  5. pmc Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
    Priscila A Tonetto
    Grupo de Estudo das Hepatites Disciplina de Moléstias Infecciosas, Departamento de Clínica Médica Faculdade de Ciências Médicas Universidade Estadual de Campinas UNICAMP, Sao Paulo, Brazil
    BMC Infect Dis 9:149. 2009
    ..The aim of this study was to determine HBV subtypes and genotypes in HBV-infected patients in our region (southeast Brazil) and to correlate results with clinical and histopathological data...
  6. pmc Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil
    Aline G Vigani
    Grupo de Estudos das Hepatites Virais, Departamento de Clinica Medica, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas UNICAMP, Sau Paulo, Brasil
    BMC Infect Dis 8:164. 2008
    ..We set out to study the natural history of HCV genotype 1 and 3 infections in Campinas, São Paulo state, Brazil, focusing on epidemiological, clinical, biochemical, and histological characteristics...
  7. ncbi request reprint Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
    Aline Gonzalez Vigani
    Viral Hepatitis Study Group, Department of Medical Clinic, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas, Campinas, Brazil
    Braz J Infect Dis 14:193-6. 2010
    ..Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment...